title: Therapy of regional lymphadenitis following BCG vaccination.
abstract: In this study we presented 92 cases with regional lymphadenitis (over 1 cm in diameter) which was caused by BCG vaccination generally performed a few days after birth. The patients were divided into four therapy groups. In group I, the lymphadenitis in 26 cases was excised totally by a surgical operation and they improved in a median period of four weeks (average: 4.4). No therapy was applied in 33 patients constituting group II and their periods of improvement were 28 weeks (average: 29.1). Sixteen cases in group III were given isoniazid (INH) 10 mg/kg for six months in addition to total surgical excision and their healing period was 4.5 weeks (average: 4). Seventeen cases in group IV were administered only INH for six months and the median improvement period was found to be 27 weeks (average: 28.2). The statistical differences in terms of the improvement periods between groups I and III, and groups II and IV were found to be insignificant (p greater than 0.05) but these differences were significant between groups I and II, groups I and IV, groups II and III, and groups III and IV (p less than 0.05). These results show that spontaneous healing is possible. Total excision is the best therapy for BCG lymphadenitis in suppurative forms and INH has no effect in shortening the therapy period.
authors.affiliation: Dept. of Pediatrics, Karadeniz Technical University, Medical Faculty, Trabzon, Turkey.
authors.forename: A
authors.initials: A
authors.lastname: Baki
authors.forename: M
authors.initials: M
authors.lastname: Oncü
authors.forename: S
authors.initials: S
authors.lastname: Usta
authors.forename: K
authors.initials: K
authors.lastname: Yildiz
authors.forename: A
authors.initials: A
authors.lastname: Karagüzel
mesh_terms: D001500:BCG Vaccine / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007538:Isoniazid / Q000627:therapeutic use; D008197:Lymph Node Excision; D008199:Lymphadenitis / Q000209:etiology / Q000628:therapy*; D013997:Time Factors; D014376:Tuberculosis / Q000517:prevention & control; D014421:Turkey; D014611:Vaccination / Q000009:adverse effects*
chemical_list: D001500:BCG Vaccine; D007538:Isoniazid